Annual accounts receivable:
$221.73M+$59.65M(+36.80%)Summary
- As of today (May 21, 2025), ANIP annual accounts receivable is $221.73 million, with the most recent change of +$59.65 million (+36.80%) on December 31, 2024.
- During the last 3 years, ANIP annual accounts receivable has risen by +$93.20 million (+72.51%).
- ANIP annual accounts receivable is now at all-time high.
Performance
ANIP Accounts receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly accounts receivable:
$220.33M-$1.39M(-0.63%)Summary
- As of today (May 21, 2025), ANIP quarterly accounts receivable is $220.33 million, with the most recent change of -$1.39 million (-0.63%) on March 31, 2025.
- Over the past year, ANIP quarterly accounts receivable has increased by +$47.92 million (+27.79%).
- ANIP quarterly accounts receivable is now -0.63% below its all-time high of $221.73 million, reached on December 31, 2024.
Performance
ANIP Quarterly accounts receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Accounts receivable Formula
Accounts Receivable = Total Credit Sales − Amount Collected from Credit Sales
ANIP Accounts receivable Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +36.8% | +27.8% |
| 3 y3 years | +72.5% | +67.4% |
| 5 y5 years | +207.4% | +167.5% |
ANIP Accounts receivable Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +72.5% | -0.6% | +67.4% |
| 5 y | 5-year | at high | +207.4% | -0.6% | +201.2% |
| alltime | all time | at high | >+9999.0% | -0.6% | >+9999.0% |
ANIP Accounts receivable History
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2025 | - | $220.33M(-0.6%) |
| Dec 2024 | $221.73M(+36.8%) | $221.73M(+12.9%) |
| Sep 2024 | - | $196.36M(+18.2%) |
| Jun 2024 | - | $166.09M(-3.7%) |
| Mar 2024 | - | $172.42M(+6.4%) |
| Dec 2023 | $162.08M(-2.0%) | $162.08M(-9.4%) |
| Sep 2023 | - | $178.84M(+3.4%) |
| Jun 2023 | - | $172.93M(-1.0%) |
| Mar 2023 | - | $174.71M(+5.6%) |
| Dec 2022 | $165.44M(+28.7%) | $165.44M(+17.8%) |
| Sep 2022 | - | $140.43M(-6.6%) |
| Jun 2022 | - | $150.41M(+14.3%) |
| Mar 2022 | - | $131.63M(+2.4%) |
| Dec 2021 | $128.53M(+34.2%) | $128.53M(+20.4%) |
| Sep 2021 | - | $106.71M(+15.2%) |
| Jun 2021 | - | $92.65M(+0.8%) |
| Mar 2021 | - | $91.88M(-4.1%) |
| Dec 2020 | $95.79M(+32.8%) | $95.79M(+14.4%) |
| Sep 2020 | - | $83.75M(+14.5%) |
| Jun 2020 | - | $73.16M(-11.2%) |
| Mar 2020 | - | $82.38M(+14.2%) |
| Dec 2019 | $72.13M(+11.2%) | $72.13M(+2.0%) |
| Sep 2019 | - | $70.70M(-7.3%) |
| Jun 2019 | - | $76.27M(+13.1%) |
| Mar 2019 | - | $67.41M(+4.0%) |
| Dec 2018 | $64.84M(+10.3%) | $64.84M(-4.1%) |
| Sep 2018 | - | $67.65M(+20.6%) |
| Jun 2018 | - | $56.12M(+2.4%) |
| Mar 2018 | - | $54.80M(-6.8%) |
| Dec 2017 | $58.79M | $58.79M(-5.4%) |
| Sep 2017 | - | $62.17M(+12.0%) |
| Jun 2017 | - | $55.51M(+18.9%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2017 | - | $46.70M(+1.7%) |
| Dec 2016 | $45.90M(+109.3%) | $45.90M(-3.3%) |
| Sep 2016 | - | $47.48M(+33.5%) |
| Jun 2016 | - | $35.56M(+58.2%) |
| Mar 2016 | - | $22.48M(+2.5%) |
| Dec 2015 | $21.93M(+26.8%) | $21.93M(+1.3%) |
| Sep 2015 | - | $21.64M(+14.6%) |
| Jun 2015 | - | $18.88M(+8.7%) |
| Mar 2015 | - | $17.37M(+0.4%) |
| Dec 2014 | $17.30M(+38.2%) | $17.30M(+18.7%) |
| Sep 2014 | - | $14.57M(+86.9%) |
| Jun 2014 | - | $7.79M(-28.5%) |
| Mar 2014 | - | $10.91M(-12.8%) |
| Dec 2013 | $12.51M(>+9900.0%) | $12.51M(+31.5%) |
| Sep 2013 | - | $9.52M(+48.0%) |
| Jun 2013 | - | $6.43M(>+9900.0%) |
| Dec 2010 | $0.00(-100.0%) | $0.00(0.0%) |
| Sep 2010 | - | $0.00(-100.0%) |
| Jun 2010 | - | $53.20K(-59.9%) |
| Mar 2010 | - | $132.70K(+105.4%) |
| Dec 2009 | $64.60K(-71.9%) | $64.60K(+68.7%) |
| Sep 2009 | - | $38.30K(-67.3%) |
| Jun 2009 | - | $117.30K(-67.1%) |
| Mar 2009 | - | $356.80K(+55.3%) |
| Dec 2008 | $229.80K(+1474.0%) | $229.80K(+178.5%) |
| Sep 2008 | - | $82.50K(+287.3%) |
| Jun 2008 | - | $21.30K(-29.5%) |
| Mar 2008 | - | $30.20K(+106.8%) |
| Dec 2007 | $14.60K(-99.9%) | $14.60K(-99.6%) |
| Sep 2007 | - | $3.60M(+0.6%) |
| Jun 2007 | - | $3.58M(+1.8%) |
| Mar 2007 | - | $3.51M(-66.6%) |
| Dec 2006 | $10.51M | $10.51M |
FAQ
- What is ANI Pharmaceuticals annual accounts receivable?
- What is the all time high annual accounts receivable for ANI Pharmaceuticals?
- What is ANI Pharmaceuticals annual accounts receivable year-on-year change?
- What is ANI Pharmaceuticals quarterly accounts receivable?
- What is the all time high quarterly accounts receivable for ANI Pharmaceuticals?
- What is ANI Pharmaceuticals quarterly accounts receivable year-on-year change?
What is ANI Pharmaceuticals annual accounts receivable?
The current annual accounts receivable of ANIP is $221.73M
What is the all time high annual accounts receivable for ANI Pharmaceuticals?
ANI Pharmaceuticals all-time high annual accounts receivable is $221.73M
What is ANI Pharmaceuticals annual accounts receivable year-on-year change?
Over the past year, ANIP annual accounts receivable has changed by +$59.65M (+36.80%)
What is ANI Pharmaceuticals quarterly accounts receivable?
The current quarterly accounts receivable of ANIP is $220.33M
What is the all time high quarterly accounts receivable for ANI Pharmaceuticals?
ANI Pharmaceuticals all-time high quarterly accounts receivable is $221.73M
What is ANI Pharmaceuticals quarterly accounts receivable year-on-year change?
Over the past year, ANIP quarterly accounts receivable has changed by +$47.92M (+27.79%)